Our multivariate analyses stratified for presence or absence of CD8+ T-cell infiltration demonstrated that the favorable prognostic effect of FOXP3+ TILs in ER– breast cancer was only significant and independent in those having HER2+/ER– tumors with concurrent CD8+ T-cell infiltrates. This evidence concerns the gene FOXP3 and breast carcinoma.